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Abstract: Background: Syphilis infection has been associated with an increased risk of HIV infection
during pregnancy which poses greater risk for maternal mortality, and antenatal syphilis point-of-care
(POC) testing has been introduced to improve maternal and child health outcomes. There is limited
evidence on the impact of syphilis POC testing on maternal outcomes in high HIV prevalent settings.
We used syphilis POC testing as a model to evaluate the impact of POC diagnostics on the improvement
of maternal mortality in KwaZulu-Natal, South Africa. Methods: We extracted 132 monthly data
points on the number of maternal deaths in facilities and number of live births in facilities for 12 tertiary
healthcare facilities in KwaZulu-Natal (KZN), South Africa from 2004 to 2014 from District Health
Information System (DHIS) health facility archived. We employed segmented Poisson regression
analysis of interrupted time series to assess the impact of the exposure on maternal mortality ratio
(MMR) before and after the implementation of antenatal syphilis POC testing. We processed and
analyzed data using Stata Statistical Software: Release 13. (Stata, Corp LP, College Station, TX, USA).
Results: The provincial average annual maternal mortality ratio (MMR) was estimated at 176.09
± 43.92 ranging from a minimum of 68.48 to maximum of 225.49 per 100,000 live births. The data
comprised 36 temporal points before the introduction of syphilis POC test exposure and 84 after
the introduction in primary health care clinics in KZN. The average annual MMR for KZN from
2004 to 2014 was estimated at 176.09 ± 43.92. A decrease in MMR level was observed during 2008
after syphilis POC test implementation, followed by a rise during 2009. Analysis of the MMR trend
estimates a significant 1.5% increase in MMR trends during the period before implementation and
1.3% increase after implementation of syphilis POC testing (p < 0.001). Conclusion: Although our
finding suggests a brief reduction in the MMR trend after the implementation of antenatal syphilis
POC testing, a continued increase in syphilis rates is seen in KwaZulu-Natal, South Africa. The
study used one of the most powerful quasi-experimental research methods, segmented Poisson
regression analysis of interrupted time series to model the impact of syphilis POC on maternal
outcome. The study finding requires confirmation by use of more rigorous primary study design.
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1. Background
South Africa accounts for 18% of global HIV infections, with approximately 6.7 million people
infected [1]. There are almost 1000 new HIV infections per day, the majority of which are heterosexually
transmitted [2]. The 2019 Statistics South Africa National Estimates report shows an ongoing increase
in total number of persons living with HIV in South Africa [3]. This number has increased from an
estimated 4.64 million in 2002 to 7.97 million by 2019 [3]. The report also shows that over a fifth of
South African women in their reproductive ages (15–49 years) are HIV positive [3]. A recent report on
maternal health indicates that non-pregnancy-related infections due to HIV/AIDS contribute to 43.7%
of the total maternal mortality in South Africa [4]. The 2014 Amnesty International report on maternal
health in KwaZulu-Natal (KZN) and Mpumalanga 2008–2010 highlights the barriers, such as poor
access to health care, resulting in women and girls delaying or avoiding antenatal care in and maternal
deaths [5].
Point-of-care (POC) testing is one innovation that has been proven to help improve healthcare
access by enabling early diagnosis and linkage to care [6]. Syphilis point-of-care (POC) testing
is provided as part of the routine antenatal services in South Africa. This was implemented to
help improve healthcare access and neonatal health outcomes [7–11]. The introduction of syphilis
POC testing has been shown to be effective in strengthening health systems by improving access
to quality-assured prenatal screening and saving new-born lives in resource-limited settings [12,13].
The results of our survey which was aimed at determining the availability and utility of POC diagnostics
in rural KZN has demonstrated that syphilis testing was available and used in all districts, but the
level of availability and use varied from clinic to clinic [14]. Overall 50% (CI: 60–40%) of the clinics
used syphilis tests [14].
Syphilis infection has been associated with HIV through facilitating HIV transmission and the
combination of syphilis, particularly during pregnancy [9,15]. Early detection of Treponema pallidum
and prompt penicillin treatment for pregnant women who test positive have been shown to be effective
in reducing adverse pregnancy outcomes [16–18]. Syphilis has also been demonstrated to increase
HIV viral load and decrease CD4 cell counts in HIV-infected patients with syphilis infections [19,20].
Atypical presentations of early syphilis, rapid progression to tertiary syphilis, treatment failures, and
more frequent cases of neurosyphilis have been reported amongst HIV-infected populations [15]. This
is a concern for low- and middle-income countries, such as South Africa, that have high rates of
HIV-related maternal mortality [5,21].
Despite this, little is known about the impact of syphilis POC testing on maternal mortality,
particularly in high HIV settings. The results of our systematic review revealed that there is limited
evidence on the impact of syphilis POC diagnostics on maternal outcomes of HIV-infected women [4].
The main aim of this study is to determine the impact of antenatal syphilis POC diagnostics on maternal
mortality in KwaZulu-Natal, South Africa, using a time series study design. Demonstrating the impact
of currently used syphilis POC testing on maternal mortality will enable us to determine whether or
not the introduction of syphilis POC diagnostics has had any tangible effect on key maternal outcomes
to enable justification of the need for syphilis POC diagnostic scale-up in settings that lack laboratory
infrastructure such as rural antenatal health clinics.
2. Methodology
This study was conducted as part of a large implementation research study aimed at evaluating
the accessibility and utility of POC diagnostics for maternal health in rural South Africa primary
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healthcare clinics (PHC) in order to generate a model framework of implementation of POC diagnostics
in rural South African clinics [22].
2.1. Study Design, Population, and Location
We conducted a retrospective study using monthly MMR data from all 11 districts in KZN
province, South Africa from 2004 to 2014. KZN province was purposively selected due to the high
prevalence of HIV and high maternal mortality. A quasi-experimental approach is a powerful approach
for evaluating effects of presence and absence of an exposure on outcomes [23,24].
2.2. Exposure
As reported by the KZN Department of Health, Rapid Plasma Reagin (RPR; Biotec Lab, Suffolk,
UK) syphilis POC testing was implemented as part of the routine diagnostic tests for antenatal care in
primary healthcare facilities during 2007. Syphilis POC test forms one the routine antenatal diagnostic
tests offered by nurses at PHC clinics. Prior to the introduction of syphilis POC testing in this region,
syphilis testing was performed at the laboratory associated with the health facility using Lovibond
(Orbeco-Hellige, FL, USA) and Rapid Plasma Reagin (RPR; Biotec Lab, Suffolk, UK), respectively.
2.3. Data Extraction
We extracted archived records on the number of annual live births and number of maternal deaths
in KZN from existing routine data from the District Health Information System (DHIS; Table S1). Earlier
studies of the DHIS system have reported that the quality of the data, including those used to track
prevention of mother to child transmission (PMTCT) care, is suboptimal [25]. Following these reports,
in 2008 the KwaZulu-Natal Department of Health, the University of KwaZulu-Natal, and the Institute
for Health care Improvement launched a large-scale effort, entitled the 20,000+ Partnership, to improve
the completeness and accuracy of the public health data routinely recorded in the DHIS implemented
between May 2008 and March 2009 [26]. This exposure has led to improved data reliability and
validity [26].
We extracted data from KZN tertiary facilities that contained data on number of maternal deaths
in the facility and number of live births in the facility from 2004 to 2014. Data prior to 2004, after 2014,
and other data that were not relevant to maternal health were excluded. The DHIS presents district
level data on all the maternal health indicators required to calculated MMR. We extracted district
level data on number of maternal deaths in facilities and number of live births in facilities to help us
calculate MMR.
2.4. Data analysis
We processed and analyzed data using Stata Statistical Software: Release 13. (College Station, TX:
StataCorp LP). The exposure (syphilis POC test) was implemented as part of the routine diagnostic tests
for antenatal care in primary healthcare facilities during 2007. Hence, we conducted a pre-post analysis
of this exposure. Estimation of the impact of syphilis POC diagnostics on overall MMR in all KZN
districts was conducted using the exposure time series approach [27]. We used the Poisson formulation
approach, given maternal death count (with live births as the exposure) to estimate changes in levels
and trends in maternal deaths during the period before and after implementation of syphilis POC
testing in KZN, using the following equation:
Yˆt = log (Lt) + β0 + β1 × time + β2 × exposure + β3 × time after exposure + et
Where Yˆt is the outcome (maternal deaths); Lt is the live birth count; time indicates the number
of months from the start of the series; exposure is the dummy variable taking the values 0 in the
pre-exposure segment and 1 in the post-exposure segment; time after exposure is 0 in the pre-exposure
segment and counts the months in the post-exposure segment at time t; the coefficient β0 estimates
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the base level of the outcome (MMR) at the beginning of the series; β1 estimates the base trend, i.e.,
the change in outcome per month in the pre-exposure segment; β2 estimates the change in level of
MMR on the post-exposure segment; β3 estimates the change in trend in MMR in the post-exposure
segment; and et estimates the error
We used line graphs to visually display the series over time namely, one curve represented the
observed MMR by year and month while a second line displayed the predicted line from the segmented
regression model. Model coefficients were exponentiated to represent relative risks (RR).
2.5. Ethics Statement
We received full ethical approval and permission to conduct this study from the KZN Department
of Heath (DoH) Ethics Committee (HRKM 40/15). We also received ethical approval for the current study
from the University of KwaZulu-Natal (UKZN) Biomedical Research Ethics Committee (BE484/14).
Data used in this study was extracted from the national database. Therefore, patient informed consent
was not required.
3. Results
Summary of the Study Population and Sample Size
A total of 132 consecutive monthly MMR data points from 12 tertiary healthcare facilities from all
11 KZN districts were assessed from 2004 to 2014. The data comprised of 36 temporal points before
the introduction of syphilis POC test exposure and 84 after the introduction in primary health care
clinics (Table S1). The average annual MMR for KZN from 2004 to 2014 was estimated at 176.09 ±
43.92 ranging from a minimum of 68.48 to a maximum of 225.49 (Table 1). Table 1 shows a drop in
MMR by 34.2% in 2008 followed by a 35.5% rise in 2009.
Table 1. Maternal mortality rate by year for all KwaZulu-Natal.
Year Number of MaternalDeaths in Facility
Number of Live
Births in Facility
Maternal Mortality Ratio
Per 100,000 Live Births
2004 208 159712 130.23
2005 259 145617 177.86
2006 371 171230 216.67
2007 337 168580 199.91
2008 120 175227 68.48
2009 324 167847 193.03
2010 291 167544 173.69
2011 378 167637 225.49
2012 312 164322 189.87
2013 256 163411 156.66
2014 254 159484 159.26
Figure 1 shows an annual increase in maternal mortality ratio (MMR) level from 2004 to 2014,
with a prominent drop in MMR level in 2008. Figure 2 shows the average and monthly fluctuations in
MMR levels. A 35% decrease in MMR level was estimated during implementation of the syphilis POC
test (p < 0.001; Table 2).
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Table 2. Longitudinal analysis of monthly maternal mortality using a fully segmented Poisson
regression model.
Full Segmented Regression Model RR 95% CI p Value
Lower Upper
A0—Intercept i (2007, introduction of POC testing) 0.001 0.001 0.001 —
A1—Baseline trend (before introduction of syphilis POC testing) 1.015 1.01 1.021 <0.001
A2—Level change after introduction of syphilis POC testing 0.653 0.567 0.752 <0.001
A3—Trend change introduction of syphilis POC testing 0.987 0.981 0.992 <0.001
Table 2 and Figure 3 depict results from the segmented Poisson regression (interrupted time series)
model. Based on the smoothed line plots and the reported relative risk (RR), there is a significant
decrease in the monthly MMR before and after the syphilis POC testing exposure in KZN (35%).
A significant 1.5% increase in MMR was observed (p < 0.001) before the introduction of syphilis POC
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testing exposure (2004–2006). MMR during the period after the introduction of syphilis POC testing
exposure (2008–2014) rose significantly by 1.3% every month (p < 0.001).
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4. Discussion
Our study shows that implementation of antenatal syphilis POC tests has the potential to improve
maternal mortality in high HIV prevalence regions. A higher increase in MMR trend during the period
before implementation (2004–2006) and a relatively lower increase MMR trend after implementation of
antenatal syphilis POC test exposure (2008–2014) was demonstrated. The increase in MMR trends
before and after the exposure were significant.
To the best of our knowledge, this is the first study that has evaluated the impact of syphilis POC
testing on MMR in a high HIV prevalence resource-limited setting. Our recent systematic review
has shown a lack of evidence on the impact of syphilis POC diagnostics on maternal outcomes of
HIV-infected patients [4]. A quasi-experimental interrupted time series design was employed to
determine the impact of syphilis POC testing on maternal mortality ratio (MMR) in KZN. An interrupted
time series is the most powerful quasi-experimental approach for evaluating effects of presence and
absence of an exposure on outcomes [24,28]. This study design has enabled estimation of the change in
MMR levels during the period of implementation, before and after implementation of syphilis POC
test intervention, leading to determination of potential exposure effect on maternal ortality. This
sharp change in the MMR trend marked the beginning of the second segment of the interrupted time
series and does not reflect the immediate effect of discontinuation of syphilis POC testing intervention.
Therefore, the interruption will occur at this data point (2007). The trend changes after this data
point (2007) reflect the potential effect of introduction of syphilis POC testing in KZN. It is also worth
noting the sharp drop after 2007 and a sharp rise in MMR in 2009, which was caused by missing data
during 2008. The model used this data analysis included an omission command for the 2008 data
points. Therefore the 2008 missing data was disregarding during analysis to ensure reliability of the
model output.
DHIS data quality was a major limitation in this study [25]. Moreover, although syphilis
infections have been associated with an increased risk of HIV transmission among pregnant women,
the prevalence of syphilis is low in KZN. Therefore, in comparison to other disease conditions such as
HIV, which have a high prevalence among women in KZN [29], the introduction of syphilis POC testing
as a single exposure will not have a substantial impact on maternal mortality. However, due to the POC
implementation dates (1998) for HIV and syphilis (2007) and the lack of archived DHIS MMR records
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prior to 2004, syphilis POC testing was the most suitable exposure for this study. During the analysis
of monthly the MMR, data outliers which may have shifted the slope of the regression segments were
detected. The sudden drop (34.2%) in MMR from 2007 to 2008 demonstrates inconsistencies in the data
set. This finding is supported by a previous study which was aimed at introducing data improvement
exposure for indicators in selected clinics in KZN in May 2008 [26]. This study revealed a significant
improvement in data completeness from 26% before introduction of the exposure to 64% after the
exposure, and also demonstrated a significant increase in data accuracy from 37% to 65% (p < 0.0001)
after the exposure [26]. This was a retrospective study that used available routine DHIS data to answer
the research question. The DHIS data did not contain the number of patients who were exposed to
syphilis testing during each year. However, we are aware that all pregnant women are offered syphilis
tests as part of routine antenatal test. Another limitation of this study is that our model only used
DHIS data, which did not include data on pre-eclampsia cases. Pre-eclampsia is the leading cause of
maternal and fetal morbidity and mortality worldwide [30–32]. It is a pregnancy-induced disorder
reported to cause complications in approximately 5–7% of pregnancies.
The 2011 World Health Organization (WHO) global HIV/AIDS response has shown that up to
one-third of the women attending antenatal care clinics are not tested for syphilis [33]. Maternal
syphilis infections continue to affect large numbers of pregnant women, causing substantial perinatal
morbidity and mortality that could be prevented by early testing and treatment [34,35]. The use of
syphilis POC testing has been shown to result in health system strengthening and saving newborn
lives [12]. Bearing in mind the reported increase in HIV-related maternal mortality in KZN [36] and
the potential impact of syphilis POC testing on reducing MMR demonstrated in this study, there is a
need for scaling up of syphilis POC testing. Although the results show the potential impact of syphilis
POC testing on reducing maternal mortality, the level of MMR is still increasing. This demonstrates
the need for additional interventions to deduce maternal mortality post-intervention.
As POC tests are being increasingly designed for use in resource-limited settings [37,38], rigorous
assessment of the impact of current and future POC tests on key health outcomes is crucial in order to
justify scale up or test replacement. This is supported by De Schacht et al. studies which recommend
the need to identify optimal health delivery strategies to effectively bring the impact of technological
advances such as POC testing to patients that are most at need [13]. Due to the recently reported
increasing prevalence of HIV among women in KZN [29], detection of treatable infections that are
associated with HIV transmission is crucial for the reduction of HIV-related maternal mortality. Future
modelling studies on the impact of POC tests in KZN should exclude MMR data collected in 2008 to
improve the reliability of the results.
5. Conclusions
The results of this study show an increasing maternal mortality ratio in KZN, South Africa. It also
demonstrated the potential impact of antenatal syphilis POC test exposure on reducing the increase
in MMR. However, the impact was in consideration of confounding factors related to MMR in these
settings, thus the results require confirmation by use of a more rigorous study design. Bearing in mind
the high importance of improving maternal outcomes in high HIV prevalent regions, efforts to help in
the continual improvement of POC testing interventions aimed at improving maternal mortality are
essential, particularly in these settings.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/2075-4418/9/4/218/s1.
Table S1, Maternal deaths by year and month for all KZN.
Author Contributions: T.P.M.-T., B.S. and P.K.D. conceptualised and designed the study. T.P.M.-T. and B.S. carried
out the analysis and produced the first draft of the manuscript. P.K.D. and D.K. commented on this draft and
contributed to the final version. All authors read and approved the final manuscript.
Funding: This study is funded by the UKZN College of Health Sciences; South African Centre of Excellence for
Epidemiology and Modelling Analysis (SACEMA), the African Population and Health Research Centre, and the
National Institute of Allergy and Infectious Disease of the National Institutes of Health (K23 AI108293).
Diagnostics 2019, 9, 218 8 of 10
Acknowledgments: We would like to that the KwaZulu-Natal Department of Health, DHIS office for granting us
access to data used for this study.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. UNAIDS. The Gap Report. Available online: http://www.unaids.org/sites/default/files/media_asset/UNAID
S_Gap_report_en.pdf (accessed on 18 November 2019).
2. Department of Health. National Strategic Plan on HIV, STIs and TB 2012–2016. Available online: https://ww
w.google.com.hk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=2ahUKEwiosYbwyZ3mAhXFGa
YKHe2XBJEQFjACegQIBRAC&url=http%3A%2F%2Fwww.health.gov.za%2Findex.php%2Fshortcodes%2
F2015-03-29-10-42-47%2F2015-04-30-08-18-10%2F2015-04-30-08-21-56%3Fdownload%3D579%3Ahiv-na
tional-strategic-plan-on-hiv-stis-and-tb-2012-2016-summary&usg=AOvVaw2VI-h6VYlAzWt1sugeKjFt
(accessed on 5 December 2019).
3. Statistics South Africa. Mid-year Population Estimates. Available online: http://www.statssa.gov.za/publicati
ons/P0302/P03022019.pdf (accessed on 3 November 2019).
4. Mashamba-Thompson, T.P.; Morgan, R.L.; Sartorius, B.; Dennis, B.; Drain, P.K.; Thabane, L. Effect of
point-of-care diagnostics on maternal outcomes in human immunodeficiency virus–infected women:
systematic review and meta-analysis. Point Care 2017, 16, 67. [CrossRef] [PubMed]
5. Amnesty International. Struggle for Maternal Health Barriers to Antenatal Care in South Africa; 2014.
Available online: https://cisp.cachefly.net/assets/articles/attachments/51965_amnesty_southafrica530062014e
n.pdf (accessed on 5 December 2019).
6. Bronzan, R.N.; Mwesigwa-Kayongo, D.C.; Narkunas, D.; Schmid, G.P.; Neilsen, G.A.; Ballard, R.C.;
Karuhije, P.; Ddamba, J.; Nombekela, E.; Hoyi, G. Onsite rapid antenatal syphilis screening with an
immunochromatographic strip improves case detection and treatment in rural South African clinics. Sex.
Transm. Dis. 2007, 34, S55–S60. [CrossRef] [PubMed]
7. Pronyk, P.; Kim, J.; Makhubele, M.; Hargreaves, J.; Mohlala, R.; Hausler, H. Introduction of voluntary
counselling and rapid testing for HIV in rural South Africa: From theory to practice. AIDS Care 2002, 14,
859–865. [CrossRef] [PubMed]
8. Dhatt, R.; Theobald, S.; Buzuzi, S.; Ros, B.; Vong, S.; Muraya, K.; Molyneux, S.; Hawkins, K.;
González-Beiras, C.; Ronsin, K. The role of women’s leadership and gender equity in leadership and
health system strengthening. Glob. HealthEpidemiol. Genom. 2017, 2. [CrossRef] [PubMed]
9. Mullick, S.; Beksinksa, M.; Msomi, S. Treatment for syphilis in antenatal care: Compliance with the three
dose standard treatment regimen. Sex. Transm. Infect. 2005, 81, 220–222. [CrossRef] [PubMed]
10. Kuupiel, D.; Tlou, B.; Bawontuo, V.; Mashamba-Thompson, T.P. Accessibility of pregnancy-related
point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana:
A cross-sectional survey. Heliyon 2019, 5, e01236. [CrossRef]
11. Kuupiel, D.; Adu, K.M.; Bawontuo, V.; Mashamba-Thompson, T.P. Geographical Accessibility to District
Hospitals/Medical Laboratories for Comprehensive Antenatal Point-of-Care Diagnostic Services in the Upper
East Region, Ghana. EClinicalMedicine 2019, 13, 74–80. [CrossRef]
12. Mabey, D.C.; Sollis, K.A.; Kelly, H.A.; Benzaken, A.S.; Bitarakwate, E.; Changalucha, J.; Chen, X.-S.; Yin, Y.-P.;
Garcia, P.J.; Strasser, S. Point-of-care tests to strengthen health systems and save newborn lives: The case of
syphilis. PLoS Med. 2012, 9, e1001233. [CrossRef]
13. De Schacht, C.; Lucas, C.; Sitoe, N.; Machekano, R.; Chongo, P.; Temmerman, M.; Tobaiwa, O.; Guay, L.;
Kassaye, S.; Jani, I.V. Implementation of point-of-care diagnostics leads to variable uptake of syphilis, anemia
and CD4+ T-Cell count testing in rural maternal and child health clinics. PLoS ONE 2015, 10, e0135744.
[CrossRef]
14. Mashamba-Thompson, T.; Sartorius, B.; Drain, P. Operational assessment of point-of-care diagnostics in rural
primary healthcare clinics of KwaZulu-Natal, South Africa: A cross-sectional survey. BMC Health Serv. Res.
2018, 18, 380. [CrossRef]
15. Lynn, W.; Lightman, S. Syphilis and HIV: A dangerous combination. Lancet Infect. Dis. 2004, 4, 456–466.
[CrossRef]
Diagnostics 2019, 9, 218 9 of 10
16. Berman, S.M. Maternal syphilis: Pathophysiology and treatment. Bull. World Health Organ. 2004, 82, 433–438.
[PubMed]
17. Blencowe, H.; Cousens, S.; Kamb, M.; Berman, S.; Lawn, J.E. Lives Saved Tool supplement detection and
treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public
Health 2011, 11, S9. [CrossRef] [PubMed]
18. Hawkes, S.; Matin, N.; Broutet, N.; Low, N. Effectiveness of interventions to improve screening for syphilis
in pregnancy: A systematic review and meta-analysis. Lancet Infect. Dis. 2011, 11, 684–691. [CrossRef]
19. Buchacz, K.; Patel, P.; Taylor, M.; Kerndt, P.R.; Byers, R.H.; Holmberg, S.D.; Klausner, J.D. Syphilis increases
HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. Aids
2004, 18, 2075–2079. [CrossRef] [PubMed]
20. Yeganeh, N.; Watts, H.D.; Camarca, M.; Soares, G.; Joao, E.; Pilotto, J.H.; Gray, G.; Theron, G.; Santos, B.;
Fonseca, R. Syphilis in HIV-infected Mothers and Infants: Results from the NICHD/HPTN 040 Study. Pediatric
Infect. Dis. J. 2015, 34, e52–e57. [CrossRef]
21. Khan, M.; Pillay, T.; Moodley, J.M.; Connolly, C.A.; Durban Perinatal TB HIV-1 Study Group. Maternal
mortality associated with tuberculosis–HIV-1 co-infection in Durban, South Africa. Aids 2001, 15, 1857–1863.
[CrossRef]
22. Mashamba-Thompson, T.; Drain, P.; Sartorius, B. Evaluating the accessibility and utility of HIV-related
point-of-care diagnostics for maternal health in rural South Africa: A study protocol. BMJ Open 2016, 6,
e011155. [CrossRef]
23. Shadish, W.R.; Cook, T.D.; Campbell, D.T. Experimental and quasi-experimental designs for generalized
causal inference. J. Am. Stat. Assoc. 2005, 100, 708.
24. Taljaard, M.; McKenzie, J.E.; Ramsay, C.R.; Grimshaw, J.M. The use of segmented regression in analysing
interrupted time series studies: An example in pre-hospital ambulance care. Implement. Sci. 2014, 9, 77.
[CrossRef]
25. Mate, K.S.; Bennett, B.; Mphatswe, W.; Barker, P.; Rollins, N. Challenges for routine health system data
management in a large public programme to prevent mother-to-child HIV transmission in South Africa.
PLoS ONE 2009, 4, e5483. [CrossRef] [PubMed]
26. Mphatswe, W.; Mate, K.S.; Bennett, B.; Ngidi, H.; Reddy, J.; Barker, P.M.; Rollins, N. Improving public health
information: A data quality intervention in KwaZulu-Natal, South Africa. Bull. World Health Organ. 2012, 90,
176–182. [CrossRef] [PubMed]
27. Wagner, A.; Soumerai, S.; Zhang, F.; Ross-Degnan, D. Segmented regression analysis of interrupted time
series studies in medication use research. J. Clin. Pharm. Ther. 2002, 27, 299–309. [CrossRef] [PubMed]
28. Campbell, D.T.; Stanley, J.C. Experimental and Quasi-Experimental Designs for Research; Ravenio Books:
2015. Available online: https://apps.who.int/iris/bitstream/handle/10665/44787/9789241502986_eng.pdf
(accessed on 5 December 2019).
29. Kharsany, A.B.; Frohlich, J.A.; Yende-Zuma, N.; Mahlase, G.; Samsunder, N.; Dellar, R.C.; Zuma-Mkhonza, M.;
Karim, S.S.A.; Karim, Q.A. Trends in HIV prevalence in pregnant women in rural South Africa. Jaids J. Acquir.
Immune Defic. Syndr. 2015, 70, 289–295. [CrossRef]
30. Lagana, A.S.; Vitale, S.G.; Sapia, F.; Valenti, G.; Corrado, F.; Padula, F.; Rapisarda, A.M.C.; D’Anna, R. miRNA
expression for early diagnosis of preeclampsia onset: Hope or hype? J. Matern.-Fetal Neonatal Med. 2018, 31,
817–821. [CrossRef]
31. Laganà, A.S.; Giordano, D.; Loddo, S.; Zoccali, G.; Vitale, S.G.; Santamaria, A.; Buemi, M.; D’Anna, R.
Decreased Endothelial Progenitor Cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as
possible early markers of preeclampsia: A case-control analysis. Arch. Gynecol. Obstet. 2017, 295, 867–872.
[CrossRef]
32. Salman, H.; Shah, M.; Ali, A.; Aziz, A.; Vitale, S.G. Assessment of Relationship of Serum Neurokinin-B Level
in the Pathophysiology of Pre-eclampsia: A Case–Control Study. Adv. Ther. 2018, 35, 1114–1121. [CrossRef]
33. WHO; UNAiDS; Unicef. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards
Universal Access: Progress Report 2011. Available online: https://scholar.google.com.hk/scholar?hl=zh-CN
&as_sdt=0%2C5&q=34.%09WHo%2C+UNAiDS%2C+Unicef.+Global+HIV%2FAIDS+response%3A+Epi
demic+update+and+health+sector+progress+towards+universal+access%3A+Progress+report+2011.&
btnG=#d=gs_cit&u=%2Fscholar%3Fq%3Dinfo%3As_Alx9YRhYMJ%3Ascholar.google.com%2F%26outp
ut%3Dcite%26scirp%3D0%26hl%3Dzh-CN (accessed on 10 December 2019).
Diagnostics 2019, 9, 218 10 of 10
34. Newman, L.; Kamb, M.; Hawkes, S.; Gomez, G.; Say, L.; Seuc, A.; Broutet, N. Global estimates of syphilis in
pregnancy and associated adverse outcomes: Analysis of multinational antenatal surveillance data. PLoS
Med. 2013, 10, e1001396. [CrossRef]
35. Moline, H.R.; Smith, J.F., Jr. The continuing threat of syphilis in pregnancy. Curr. Opin. Obstet. Gynecol. 2016,
28, 101–104. [CrossRef]
36. Lebastchi, A.H.; Yuh, D.D. Nationwide survey of US integrated 6-year cardiothoracic surgical residents.
J. Thorac. Cardiovasc. Surg. 2014, 148, 401–407. [CrossRef] [PubMed]
37. Drain, P.K.; Hyle, E.P.; Noubary, F.; Freedberg, K.A.; Wilson, D.; Bishai, W.R.; Rodriguez, W.; Bassett, I.V.
Diagnostic point-of-care tests in resource-limited settings. Lancet Infect. Dis. 2014, 14, 239–249. [CrossRef]
38. Mabey, D.; Peeling, R.W.; Ustianowski, A.; Perkins, M.D. Diagnostics for the developing world. Nat. Rev.
Microbiol. 2004, 2, 231–240. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
